News on BvcaEuropean Private Equity from BioPortfolio.com http://www.BioPortfolio.com Consolidated BvcaEuropean Private Equity news from BioPortfolio.com Wed, 10 Feb 2010 08:19:53 GMT en South Ocean Growth Equity to become a stakeholder in Sanomedics International Holdingshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039936&HITNO=0&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039936&THISHREF=http://c.moreover.com/click/here.pl%3fz2538487424%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4039936&HITNO=0&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4039936&THISHREF=http://c.moreover.com/click/here.pl%3fz2538487424%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comNews-Medical.Net: Stocks That Stand Out For Feb. 9th, 2010 Are Feb 09, 2010 - ChinaTel Group, Inc. (OTC Bulletin Board: CHTL), Fhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038814&HITNO=1&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038814&THISHREF=http://c.moreover.com/click/here.pl%3fz2537783092%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4038814&HITNO=1&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4038814&THISHREF=http://c.moreover.com/click/here.pl%3fz2537783092%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: S&P Equity Research; Health Care Reform After The Buzzsaw - Where Are We Now?http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032370&HITNO=2&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032370&THISHREF=http://c.moreover.com/click/here.pl%3fz2534631342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032370&HITNO=2&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032370&THISHREF=http://c.moreover.com/click/here.pl%3fz2534631342%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: South Ocean Growth Equity Takes Stake in Sanomedicshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035236&HITNO=3&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035236&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035236&HITNO=3&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035236&THISHREF=http://c.moreover.com/click/here.pl%3fz2536162924%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFreshnews.com: NY S&P Healthcarehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032371&HITNO=4&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032371&THISHREF=http://c.moreover.com/click/here.pl%3fz2534631881%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4032371&HITNO=4&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4032371&THISHREF=http://c.moreover.com/click/here.pl%3fz2534631881%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comPharmacy Choice: Orion Group Financial Statement Release of 2009 - Zibb.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034310&HITNO=5&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034310&THISHREF=http://c.moreover.com/click/here.pl%3fz2535708720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034310&HITNO=5&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034310&THISHREF=http://c.moreover.com/click/here.pl%3fz2535708720%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comZibb: South Ocean Growth Equity Takes Stake in Sanomedicshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037159&HITNO=6&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037159&THISHREF=http://c.moreover.com/click/here.pl%3fz2536925199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037159&HITNO=6&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037159&THISHREF=http://c.moreover.com/click/here.pl%3fz2536925199%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comYahoo! Canada: Orion Group Financial Statement Release of 2009http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034630&HITNO=7&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034630&THISHREF=http://c.moreover.com/click/here.pl%3fz2535895788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4034630&HITNO=7&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4034630&THISHREF=http://c.moreover.com/click/here.pl%3fz2535895788%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comTherapeutics Daily: GEO Monitor IPO Newsflash: Sichuan Kelun Pharmaceutical Co. Ltd A shareshttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037600&HITNO=8&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037600&THISHREF=http://c.moreover.com/click/here.pl%3fz2537176142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037600&HITNO=8&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037600&THISHREF=http://c.moreover.com/click/here.pl%3fz2537176142%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comResearch Oracle: (OTCBB: AMCG) Issued Buy Rating and Price Target of $1.44http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037358&HITNO=9&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037358&THISHREF=http://c.moreover.com/click/here.pl%3fz2537044922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4037358&HITNO=9&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4037358&THISHREF=http://c.moreover.com/click/here.pl%3fz2537044922%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGenetic Engineering News: PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036167&HITNO=10&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036167&THISHREF=http://c.moreover.com/click/here.pl%3fz2536517985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4036167&HITNO=10&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4036167&THISHREF=http://c.moreover.com/click/here.pl%3fz2536517985%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comFOXBusiness.com: PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltd.http://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035973&HITNO=11&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035973&THISHREF=http://c.moreover.com/click/here.pl%3fz2536438073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035973&HITNO=11&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035973&THISHREF=http://c.moreover.com/click/here.pl%3fz2536438073%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comIndividual.com: Advocacy group hosting discussion of medical coverage for mental health, substance abusehttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035569&HITNO=12&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035569&THISHREF=http://c.moreover.com/click/here.pl%3fz2536275245%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035569&HITNO=12&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035569&THISHREF=http://c.moreover.com/click/here.pl%3fz2536275245%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGrand Rapids Press: PuraMed BioScience Secures up to $7.5 Million Funding Commitment From Southridge Partners II, Ltdhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035190&HITNO=13&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035190&THISHREF=http://c.moreover.com/click/here.pl%3fz2536153500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035190&HITNO=13&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035190&THISHREF=http://c.moreover.com/click/here.pl%3fz2536153500%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via Yahoo!: PuraMed BioScience Secures up to $7.5 Million Funding Commitmenthttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035160&HITNO=14&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035160&THISHREF=http://c.moreover.com/click/here.pl%3fz2536143566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comhttp://www.bioportfolio.co.uk/cgi-bin/dialogserver.exe?CMD=hit.displayMdoc&ID=4035160&HITNO=14&MSIZE=758&LANGUAGE=en&FILE=doc.NEWSFEED&SAVEQUERY00=BvcaEuropean%20Private%20Equity&SAVEPROP00=L%3den&SAVEDB=news&SAVEORGANISE_CODED=R:date&R=4035160&THISHREF=http://c.moreover.com/click/here.pl%3fz2536143566%26amp%3bz%3d950242273&THEHOST=site+d.moreover.comGlobeNewswire via MSN Money: